Blog

Juan Gómez Rivas: New Study by Pieter Vynckier et al. on prostate cancer

Photo taken from Juan Gómez Rivas/X

May 26, 2024, 09:32

Juan Gómez Rivas: New Study by Pieter Vynckier et al. on prostate cancer

Juan Gómez Rivas, Associate Professor at The Complutense University of Madrid, made the following post on X:

“New Study Alert!

In Europe, prostate cancer is the leading cancer among men. A recent systematic review highlights the cost-effectiveness of PCa screening programs. Findings suggest risk-based screening followed by MRI is a promising strategy.”

Read further.
Source: Juan Gómez Rivas/X
.

Associate Professor cancer cost-effectiveness europe Juan Gómez Rivas leading cancer men MRI OncoDaily Oncology PCa screening programs Pieter Vynckier promising strategy prostate cancer risk-based screening systematic review The Complutense University of Madrid

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage